NCT02632149
Unknown
Early Phase 1
The Clinical Research on PINS Vagus Nerve Stimulator for Treatment of Lennox-Gastaut in Children
ConditionsLennox-Gastaut Syndrome
Overview
- Phase
- Early Phase 1
- Intervention
- Not specified
- Conditions
- Lennox-Gastaut Syndrome
- Sponsor
- Beijing Pins Medical Co., Ltd
- Enrollment
- 31
- Locations
- 5
- Primary Endpoint
- Changes in seizure frequency from baseline to the seizure count evaluation period 6 month
- Last Updated
- 9 years ago
Overview
Brief Summary
The purpose of this study is to evaluate the clinical effectiveness of PINS vagus nerve stimulatior in children with Lennox-Gastaut Syndrome.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Age 3-14 year
- •Lennox - Gastaut syndrome diagnostic standard
- •Regular drug treatment is invalid
- •Antiepileptic drug stability in recent 3 months
- •Good health except epilepsy
- •Patients or his(her) familyscould understand this method and sign the informed consent
- •Patients with good compliance and could complete postoperative follow-up.
Exclusion Criteria
- •Results of MRI remind epilepsy caused by intracranial space-occupying lesions
- •Had epileptic foci excision surgery or corpus callosum
- •The vagus nerve lesion and damage
- •Tumor, cardiopulmonary anomaly, progressive neurological diseases, asthma, mental disease,peptic ulcer,diabetes Type 1,bad health etc, and other surgical contraindication
- •Participated in other clinical drug test subjects within three months
- •The researchers think that is not suitable for participants'
Outcomes
Primary Outcomes
Changes in seizure frequency from baseline to the seizure count evaluation period 6 month
Time Frame: 6 month of stimulation
Secondary Outcomes
- Changes in seizure frequency from baseline to the seizure count evaluation period(1,3,6,months of stimulation)
- Change from Baseline in the Engel and McHugh description(At 1,3,6 months)
- Overall WISC Score in Patients from Baseline(Mean change from baseline WISC Overall Score at 1,3,6months)
Study Sites (5)
Loading locations...
Similar Trials
Unknown
Early Phase 1
Clinical Trial of Vagus Nerve Stimulation for Treatment of Refractory EpilepsyRefractory EpilepsyNCT02378792Beijing Pins Medical Co., Ltd300
Unknown
Not Applicable
Prospective Cohort Study on the Efficacy of Vagus Nerve Stimulation for Children and Adolescents With Epilepsy(PVNS-CAE)Epileptic EncephalopathyNCT02603991Beijing Pins Medical Co., Ltd1
Completed
Not Applicable
Evaluating the Impact of Vagus Nerve Stimulation on Diabetic Peripheral Neuropathic PainDiabetes MellitusDiabetic NeuropathiesType2diabetesNeuropathic PainNCT06292962Saima Abass Tahammal165
Completed
Not Applicable
Effect of Transcutaneous Vagus Nerve Stimulation on Upper Limb Function in Stroke PatientsStroke, IschemicNCT06048055Cairo University40
Terminated
Phase 3
Vagus Nerve Stimulation a New Approach in the Treatment of Crohn's DiseaseCrohn's DiseaseNCT01569503University Hospital, Grenoble9